Institutional Safety Committee (ISC)
Copyright © 2024 National Biodefense Analysis and Countermeasures Center
Institutional Safety Committee (ISC)
Microorganisms not known to cause disease in healthy adult humans (Bacillus subtilis, infectious canine hepatitis)
Indigenous, moderate-risk microorganisms and toxins associated with human disease of varying severity (Hepatitis B virus, Salmonella species, botulinum neurotoxin). Preventatives and/or therapeutics are often available. These pathogens are generally manipulated at Biosafety Level 2 which is similar to a typical university or hospital laboratory.
Indigenous or exotic agents where the potential for infection by aerosol exists and disease may have serious to lethal consequences (Yellow fever virus, Venezuelan equine encephalitis). Preventatives and/or therapeutics may be available. These pathogens are typically manipulated at Biosafety Level 3 which is also referred to as “high containment”.
Dangerous and exotic microorganisms that pose a high risk of life-threatening disease (Lassa fever virus, Ebola virus, Marburg virus). Preventatives and/or therapeutics are not usually available. These pathogens are manipulated at Biosafety Level 4 which is also referred to as “maximum containment”.
Disinfection or sterilization of infected articles to make them suitable for use (6 log reduction in microbial load).
Selective elimination of certain undesirable microorganisms in order to prevent their transmission (e.g., 1:10 bleach solution wipe down of BSC
Biological Safety Cabinet. An enclosure designed to protect the worker, product and environment from exposure to microbiological agents through filtration and airflow.
“Glovebox”. An enclosure providing the highest level of microbial containment, designed to protect the worker, product and environment from exposure to microbiological agents. Work is performed in the gas-tight enclosure through arm-length gloves.
Please direct any questions regarding NBACC’s IACUC to questions@st.dhs.gov.